Myocardiofibrosis in Convalescents after Coronavirus Infection (Clinical Case)
Tuberculosis, Lung Diseases, HIV Infection · 26.03.2026 · (1) · 48-54
DOI: 10.30978/tb2026-1-48 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberculosis, Lung Diseases, HIV Infection, online erschienen am 26.03.2026. Verfasst von I.D. Duzhyi und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Myocardial fibrosis (MF) is a complication of the inflammatory process of the heart muscle (cardiomyocytes) that occurs as a result of viral or bacterial infections. Coronavirus infection, causing hypoxaemia with subsequent hypoxia, can provoke irreversible changes in target organs, including cardiomyocytes. Replacement of muscle tissue with fibrous tissue leads to cardiac dysfunction, which is clinically manifested by shortness of breath, chest pain, oedema, ascites, and hydrothorax. Against the background of respiratory failure caused by severe coronavirus disease, it is not always possible to conduct a differential diagnosis to the required extent and establish the presence of myocarditis, which is the basis for the development of myocardial fibrosis, in a timely manner. The danger of myocardial fibrosis lies in the inability of the heart to pump blood and, consequently, fluid retention, especially in the lungs, which may cause acute cardiovascular failure and death, highlighting the relevance of the problem. Objective — to study the peculiarities of myocarditis and myocardial fibrosis development in patients with different ourses of coronavirus disease, timely diagnosing myocardial inflammation as the basis of MF, focusing on predictors of the inflammatory process (C-reactive protein, D-dimer, procalcitonin and troponin). Materials and methods. We observed two patients (a male with severe coronavirus disease and a female with mild coronavirus disease) who developed myocarditis in the setting of hypoxia and viral intoxication, which manifested in both patients 6 months after coronavirus infection. Erythrocyte saturation at the inpatient stage indicated the presence of hypoxia (78—80 %). These patients were young adults, aged 41 and 35 years. Results and discussion. The patients we observed were clinically characterised by fever, asthenic-neurotic syndrome, catarrhal manifestations and respiratory failure. Dyspnoea, oedema, burning pain and chest discomfort indicated the presence of heart failure. Erythrocyte saturation was 78—80 % in the patient with severe disease and 90—92 % in the patient with mild disease. Echocardiography revealed expansion of the heart chambers and a decrease in cardiac output fractions to 17 % in the first patient and a decrease in ejection fraction to 17 % in the first patient and 35 % in the second patient. Conclusions. Coronavirus infection causes ischaemia of all organs and tissues, including the heart, against which the development of cardiac fibrosis is possible.
Zitieren
APA
Duzhyi, I., Prystupa, L., Kravets, O., Danylenko, I., Klochko, A., & Elastal, R. (2026). Myocardiofibrosis in Convalescents after Coronavirus Infection (Clinical Case). Tuberculosis, Lung Diseases, HIV Infection, 48-54. https://doi.org/10.30978/tb2026-1-48
Vancouver
Duzhyi I, Prystupa L, Kravets O, Danylenko I, Klochko A, Elastal R. Myocardiofibrosis in Convalescents after Coronavirus Infection (Clinical Case). Tuberculosis, Lung Diseases, HIV Infection. 2026:48-54. doi:10.30978/tb2026-1-48
BibTeX
@article{Duzhyi2026,
author = {Duzhyi, I.D. and Prystupa, L.N. and Kravets, O.V. and Danylenko, I.A. and Klochko, A.D. and Elastal, R.Z.},
title = {Myocardiofibrosis in Convalescents after Coronavirus Infection (Clinical Case)},
journal = {Tuberculosis, Lung Diseases, HIV Infection},
year = {2026},
number = {1},
pages = {48--54},
doi = {10.30978/tb2026-1-48}
}
EUVIMED